FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease
The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older.
The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older.
On loss, regret, grief, gratitude, and the unexplainably transcendent. Thank you for all you taught me Dad ❤️Episodes over the years featuring my dad: https:…
In patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) of the culprit lesion reduces the risk of cardiovascular death or myocardial infarction…
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
On loss, regret, grief, gratitude, and the unexplainably transcendent. Thank you for all you taught me Dad ❤️Episodes over the years featuring my dad: https:…
Innovative physician-scientist specializing in head and neck, pancreatic cancers also known as influential mentor
9071 Background: Despite its direct correlation with quality of life, sexual dysfunction is under-discussed and underreported in patients with lung cancer (LC). Sexual dysfunction is…
Walmart, the largest retailer in the United States, will close all 51 of its health care clinics in six states and end virtual health care…
FDA is alerting health care professionals of the rare risk of intrahepatic cholestasis of pregnancy (ICP) associated with the use of thiopurines.
One zebra was still on the loose, after it and three others escaped a trailer in North Bend, Wash. Dozens of people scrambled to help…
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.